TAK-242 dampens the development of immunoinflammatory and autoimmune diseases in different animal models such as an amyotrophic lateral sclerosis, experimental autoimmune myositis, and deficiency of IL-36Ra [48–50]. Here, IL36RN is linked to amyotrophic lateral sclerosis.